Shepherd Financial Partners’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$574K Sell
6,921
-1,284
-16% -$106K 0.06% 142
2025
Q1
$665K Sell
8,205
-1,011
-11% -$82K 0.08% 136
2024
Q4
$830K Sell
9,216
-1,234
-12% -$111K 0.1% 109
2024
Q3
$1.03M Buy
10,450
+1,298
+14% +$128K 0.12% 95
2024
Q2
$848K Buy
9,152
+296
+3% +$27.4K 0.11% 108
2024
Q1
$840K Buy
8,856
+1,595
+22% +$151K 0.11% 113
2023
Q4
$648K Sell
7,261
-10,260
-59% -$916K 0.09% 125
2023
Q3
$1.28M Sell
17,521
-1,900
-10% -$139K 0.2% 75
2023
Q2
$1.62M Sell
19,421
-2,126
-10% -$177K 0.25% 67
2023
Q1
$1.64M Buy
21,547
+1,966
+10% +$150K 0.27% 61
2022
Q4
$1.63M Sell
19,581
-51
-0.3% -$4.23K 0.29% 61
2022
Q3
$1.56M Buy
19,632
+11,836
+152% +$939K 0.3% 61
2022
Q2
$579K Sell
7,796
-233
-3% -$17.3K 0.11% 102
2022
Q1
$717K Sell
8,029
-5,957
-43% -$532K 0.13% 103
2021
Q4
$1.57M Sell
13,986
-298
-2% -$33.4K 0.27% 69
2021
Q3
$1.8M Buy
14,284
+121
+0.9% +$15.2K 0.35% 59
2021
Q2
$1.92M Buy
14,163
+1,720
+14% +$233K 0.36% 57
2021
Q1
$1.69M Buy
12,443
+395
+3% +$53.6K 0.37% 58
2020
Q4
$1.7M Buy
12,048
+340
+3% +$47.9K 0.39% 61
2020
Q3
$1.31M Buy
11,708
+888
+8% +$99K 0.31% 67
2020
Q2
$1.21M Buy
10,820
+26
+0.2% +$2.91K 0.33% 56
2020
Q1
$835K Sell
10,794
-650
-6% -$50.3K 0.29% 56
2019
Q4
$1.09M Buy
11,444
+556
+5% +$53K 0.25% 65
2019
Q3
$828K Hold
10,888
0.21% 65
2019
Q2
$955K Buy
10,888
+23
+0.2% +$2.02K 0.18% 63
2019
Q1
$984K Buy
10,865
+353
+3% +$32K 0.19% 62
2018
Q4
$753K Sell
10,512
-4,713
-31% -$338K 0.16% 67
2018
Q3
$1.45M Hold
15,225
0.33% 46
2018
Q2
$1.47M Buy
15,225
+12,253
+412% +$1.18M 0.33% 46
2018
Q1
$260K Buy
+2,972
New +$260K 0.06% 101